How can biotechnology DAOs design their architecture to break the pharmaceutical deadlock?
A thriving decentralized science (DeSci) movement is changing the landscape of the biopharmaceutical industry, fostering the formation of patient- and researcher-centered communities based on an open-source spirit.
